We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
176
Quanta Services
PWR
$93.9B
$19.1M 0.12%
75,096
-3,352
-4% -$888K
CM icon
177
Canadian Imperial Bank of Commerce
CM
$107B
$19.1M 0.12%
400,748
+36,101
+10% +$1.75M
STLD icon
178
Steel Dynamics
STLD
$35.6B
$19M 0.12%
146,509
+133,185
+1,000% +$17.8M
HAL icon
179
Halliburton
HAL
$27.9B
$18.9M 0.11%
560,733
+3,271
+0.6% +$121K
FSLR icon
180
First Solar
FSLR
$21.8B
$18.9M 0.11%
83,897
-122,312
-59% -$26.7M
DYN icon
181
Dyne Therapeutics
DYN
$4.04B
$18.8M 0.11%
533,273
-142,351
-21% -$4.14M
EBAY icon
182
eBay
EBAY
$48.6B
$18.7M 0.11%
348,328
+90,836
+35% +$4.73M
SWK icon
183
Stanley Black & Decker
SWK
$14.2B
$18.7M 0.11%
234,154
+22,151
+10% +$1.95M
KURA icon
184
Kura Oncology
KURA
$922M
$18.7M 0.11%
906,482
+255,065
+39% +$5.24M
EW icon
185
Edwards Lifesciences
EW
$47.6B
$18.5M 0.11%
200,325
+150,662
+303% +$13.3M
DAR icon
186
Darling Ingredients
DAR
$9.93B
$18.5M 0.11%
502,409
+35,951
+8% +$1.49M
IR icon
187
Ingersoll Rand
IR
$33B
$18.1M 0.11%
199,419
+5,797
+3% +$533K
LNTH icon
188
Lantheus
LNTH
$6.82B
$18M 0.11%
224,530
-182,223
-45% -$13.4M
FISV
189
Fiserv Inc
FISV
$27.2B
$18M 0.11%
120,701
-64,733
-35% -$9.8M
AZO icon
190
AutoZone
AZO
$48.3B
$17.8M 0.11%
6,011
+59
+1% +$173K
KKR icon
191
KKR & Co
KKR
$89.2B
$17.7M 0.11%
167,967
+4,976
+3% +$507K
MIRM icon
192
Mirum Pharmaceuticals
MIRM
$6.89B
$17.4M 0.11%
+508,475
New +$13.3M
WSM icon
193
Williams-Sonoma
WSM
$26.7B
$17.4M 0.11%
123,028
-16,776
-12% -$2.5M
JXN icon
194
Jackson Financial
JXN
$8.32B
$17.3M 0.1%
232,546
-13,337
-5% -$953K
BRO icon
195
Brown & Brown
BRO
$22.9B
$17.2M 0.1%
192,135
-826
-0.4% -$71.7K
STN icon
196
Stantec
STN
$7.69B
$17.1M 0.1%
204,405
+144,948
+244% +$11.8M
DNLI icon
197
Denali Therapeutics
DNLI
$3.67B
$16.9M 0.1%
726,499
+278,621
+62% +$5.35M
EL icon
198
Estee Lauder
EL
$29B
$16.8M 0.1%
157,826
-102,958
-39% -$13.5M
DOV icon
199
Dover
DOV
$27.2B
$16.6M 0.1%
91,857
-892
-1% -$160K
URI icon
200
United Rentals
URI
$71.1B
$16.5M 0.1%
25,590
+19,162
+298% +$12.7M

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.